| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Revenue | $3.4B | $3.4B | $3.6B | $3.6B | $3.5B | $2.8B |
| Cost of Revenue | $2.1B | $2.0B | $2.2B | $2.3B | $2.1B | $1.8B |
| Gross Profit | $1.4B | $1.4B | $1.4B | $1.3B | $1.3B | $1.0B |
| R&D Expense | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| SG&A Expense | $0.9B | $0.9B | $0.9B | $0.9B | $0.9B | $0.8B |
| Operating Income | $0.5B | $0.5B | $0.5B | $0.4B | $0.5B | $0.2B |
| Net Income | $0.3B | $0.2B | $0.2B | $0.2B | $0.3B | $0.1B |
| EPS (Basic) | $0.98 | $0.75 | $0.86 | $0.78 | $1.02 | $0.27 |
| EPS (Diluted) | $0.96 | $0.74 | $0.84 | $0.77 | $1.00 | $0.27 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Total Assets | $7.2B | $6.8B | $7.3B | $7.2B | $7.5B | $7.4B |
| Current Assets | $2.5B | $2.3B | $2.4B | $2.3B | $2.3B | $1.9B |
| Cash & Equivalents | $0.8B | $0.7B | $0.7B | $0.6B | $0.7B | $0.5B |
| Total Liabilities | $3.5B | $3.4B | $3.7B | $3.7B | $4.1B | $4.2B |
| Current Liabilities | $0.7B | $0.7B | $0.8B | $0.8B | $0.9B | $0.7B |
| Stockholders' Equity | $3.3B | $3.0B | $3.2B | $3.1B | $3.1B | $2.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.5B | $0.4B | $0.5B | $0.3B | $0.4B | $0.3B |
| Investing Cash Flow | $-0.1B | $-0.1B | $-0.1B | $-0.1B | $-0.1B | $-0.1B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.3B | $-0.3B | $-0.3B | $-0.3B | $-0.1B | $-0.4B |